These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 27777883)

  • 1. Factors associated with cervical cancer screening in a safety net population.
    Heberer MA; Komenaka IK; Nodora JN; Hsu CH; Gandhi SG; Welch LE; Bouton ME; Aristizabal P; Weiss BD; Martinez ME
    World J Clin Oncol; 2016 Oct; 7(5):406-413. PubMed ID: 27777883
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sociodemographic factors of Pap smear screening in Taiwan.
    Wang PD; Lin RS
    Public Health; 1996 Mar; 110(2):123-7. PubMed ID: 8901257
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pap smear rates among Haitian immigrant women in eastern Massachusetts.
    Green EH; Freund KM; Posner MA; David MM
    Public Health Rep; 2005; 120(2):133-9. PubMed ID: 15842114
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of a mobile unit on changes in knowledge and use of cervical cancer screening among rural Thai women.
    Swaddiwudhipong W; Chaovakiratipong C; Nguntra P; Mahasakpan P; Lerdlukanavonge P; Koonchote S
    Int J Epidemiol; 1995 Jun; 24(3):493-8. PubMed ID: 7672887
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A mobile unit: an effective service for cervical cancer screening among rural Thai women.
    Swaddiwudhipong W; Chaovakiratipong C; Nguntra P; Mahasakpan P; Tatip Y; Boonmak C
    Int J Epidemiol; 1999 Feb; 28(1):35-9. PubMed ID: 10195661
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Health literacy as a predictor of follow-up after an abnormal Pap smear: a prospective study.
    Lindau ST; Basu A; Leitsch SA
    J Gen Intern Med; 2006 Aug; 21(8):829-34. PubMed ID: 16881942
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The burden of prevention: downstream consequences of Pap smear testing in the elderly.
    Sirovich BE; Gottlieb DJ; Fisher ES
    J Med Screen; 2003; 10(4):189-95. PubMed ID: 14738656
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Attendance rate in the Polish Cervical Cancer Screening Program in the years 2007-2009].
    Spaczyński M; Karowicz-Bilinska A; Rokita W; Molińska-Glura M; Januszek-Michalecka L; Seroczyński P; Uchlik J; Nowak-Markwitz E
    Ginekol Pol; 2010 Sep; 81(9):655-63. PubMed ID: 20973201
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pap smear screening in an urban STD clinic. Yield of screening and predictors of abnormalities.
    Shlay JC; McGill WL; Masloboeva HA; Douglas JM
    Sex Transm Dis; 1998 Oct; 25(9):468-75. PubMed ID: 9800258
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The cervical cancer screening programme in Norway, 1992-2000: changes in Pap smear coverage and incidence of cervical cancer.
    Nygård JF; Skare GB; Thoresen SØ
    J Med Screen; 2002; 9(2):86-91. PubMed ID: 12133929
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Breast and cervical cancer screening in obese minority women.
    Ferrante JM; Chen PH; Jacobs A
    J Womens Health (Larchmt); 2006 Jun; 15(5):531-41. PubMed ID: 16796480
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Breast and cervical cancer screening utilization among Hispanic women living near the United States-Mexico border.
    Nuño T; Castle PE; Harris R; Estrada A; García F;
    J Womens Health (Larchmt); 2011 May; 20(5):685-93. PubMed ID: 21428792
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Papanicolaou smear history and diagnosis of invasive cervical carcinoma among members of a large prepaid health plan.
    Sung HY; Kearney KA; Miller M; Kinney W; Sawaya GF; Hiatt RA
    Cancer; 2000 May; 88(10):2283-9. PubMed ID: 10820350
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cervical cancer risk levels in Turkey and compliance to the national cervical cancer screening standard.
    Açikgöz A; Ergör G
    Asian Pac J Cancer Prev; 2011; 12(4):923-7. PubMed ID: 21790227
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cervical cancer screening among women ≥70 years of age in the United States-A referral problem or patient choice.
    Guo F; Hirth JM; Berenson AB
    Prev Med; 2015 Dec; 81():427-32. PubMed ID: 26500084
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adherence to breast and cervical cancer screening in Spanish women with diabetes: associated factors and trend between 2006 and 2010.
    Martinez-Huedo MA; Lopez de Andres A; Hernandez-Barrera V; Carrasco-Garrido P; Martinez Hernandez D; Jiménez-Garcia R
    Diabetes Metab; 2012 Apr; 38(2):142-8. PubMed ID: 22078638
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Accuracy of Screening Tools for Pap Smears in General Practice.
    Harding C; Seal A; Pilotto L; Mackey K; Duncan G; Huynh R; McWilliam R; Blake S
    J Innov Health Inform; 2016 Sep; 23(3):835. PubMed ID: 28059690
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differences in Breast and Cervical Cancer Screening Rates in Jordan among Women from Different Socioeconomic Strata: Analysis of the 2012 Population-Based Household Survey.
    Al Rifai R; Nakamura K
    Asian Pac J Cancer Prev; 2015; 16(15):6697-704. PubMed ID: 26434897
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pap smear screening in women 65 and older.
    Wheat ME; Mandelblatt JS; Kunitz G
    J Am Geriatr Soc; 1988 Sep; 36(9):827-30. PubMed ID: 3411068
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pap smear screening among urban Southwestern American Indian women.
    Risendal B; DeZapien J; Fowler B; Papenfuss M; Giuliano A
    Prev Med; 1999 Dec; 29(6 Pt 1):510-8. PubMed ID: 10600432
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.